Statistics

Total Visits

Views
BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer34

Select a period of time:

Number of views in the range

Views
BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer21

Views

Views
October 20240
November 20240
December 20240
January 20251
February 20254
March 202516
April 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore16
United States4
Germany1
 

Top cities views

Views
Huntington Beach1
Los Angeles1